|
Re: Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell
|
5
|
Resverlogix Corp.
|
Mar 19, 2021 12:32AM
|
|
Re: Happy New Years
|
5
|
Resverlogix Corp.
|
Dec 31, 2023 08:05PM
|
|
Re: Nuts and Bolts of Rescheduling
|
5
|
Resverlogix Corp.
|
Aug 25, 2016 09:37PM
|
|
Re: RESVERLOGIX AND MEDISON PHARMA LTD. ANNOUNCE STRATEGIC LICENSING AGREEMENT
|
5
|
Resverlogix Corp.
|
Jan 08, 2018 06:03PM
|
|
Re: Nuts and Bolts of Rescheduling
|
5
|
Resverlogix Corp.
|
Aug 25, 2016 10:20PM
|
|
Re: Annual Financial Reporting
|
5
|
Zenith Epigenetics
|
Mar 22, 2024 03:15PM
|
|
Re: Biotechs like Resverlogix are driven by ''projections and emotions''
|
5
|
Resverlogix Corp.
|
Sep 10, 2015 01:54PM
|
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
5
|
Resverlogix Corp.
|
Apr 20, 2021 03:26PM
|
|
AGM Comments
|
5
|
Resverlogix Corp.
|
Jun 21, 2022 04:11PM
|
|
Re: Rough waters on the investment ocean.....
|
5
|
Resverlogix Corp.
|
Jan 08, 2016 10:36AM
|
|
RVX Unrecognized Deferred Tax Benefit of $51MM(USD),$67MM(CAD... at April 30, 2016
|
5
|
Resverlogix Corp.
|
Oct 04, 2016 06:45PM
|
|
LIFTOFF!
|
5
|
Resverlogix Corp.
|
Nov 06, 2015 10:09PM
|
|
Re: A Fictitious Conversation at a Fictitious Company
|
5
|
Resverlogix Corp.
|
Sep 08, 2016 03:44PM
|
|
Re: Don On 630 CHED's Afternoon Show
|
5
|
Resverlogix Corp.
|
Jan 20, 2022 05:35PM
|
|
Ray Kroc
|
5
|
Resverlogix Corp.
|
Aug 22, 2020 06:27PM
|
|
Re: Barron's rating; albeit a single analyst:
|
5
|
Resverlogix Corp.
|
Dec 07, 2022 09:39AM
|
|
Re: Today's trading...
|
5
|
Resverlogix Corp.
|
Sep 01, 2020 09:28PM
|
|
Re: Zenith Updates
|
5
|
Zenith Epigenetics
|
Jan 30, 2016 01:05PM
|
|
Re: 2023 Outlook per MD&A
|
5
|
Resverlogix Corp.
|
Apr 07, 2023 03:05PM
|
|
Re: Cost of Dilution/Public Offering v Private Placement
|
5
|
Resverlogix Corp.
|
Oct 08, 2020 06:23PM
|
